Variant report

Variant	rs11225256
Chromosome Location	chr11:102321534-102321535
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	SIN3A	chr11:102321431-102321795	GM12878	blood:	n/a	n/a
2	RCOR1	chr11:102321476-102324349	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:102216212..102220028-chr11:102319803..102324997,8	K562	blood:
2	chr11:102321122..102328963-chr11:102333676..102341979,14	MCF-7	breast:
3	chr11:102215215..102219130-chr11:102321135..102324493,6	K562	blood:
4	chr11:102320576..102325526-chr11:102337005..102343107,13	MCF-7	breast:

Variant related genes	Relation type
ENSG00000255337	TF binding region
TMEM123	TF binding region
ENSG00000152558	Chromatin interaction
ENSG00000110330	Chromatin interaction
ENSG00000255482	Chromatin interaction

Extended variants
information (count: 10 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:6)

rs_ID	r²[population]
rs11225268	1.00[AMR][1000 genomes]
rs11501353	1.00[AMR][1000 genomes]
rs12285070	1.00[AMR][1000 genomes]
rs12285840	1.00[AMR][1000 genomes]
rs12288849	1.00[AMR][1000 genomes]
rs9971393	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv3514195	chr11:102118479-102348362	Weak transcription Flanking Active TSS Active TSS Strong transcription Genic enhancers ZNF genes & repeats Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
2	esv3514197	chr11:102118479-102348362	ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
3	nsv1035567	chr11:102264516-102431607	Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
4	nsv898334	chr11:102272884-102353192	Weak transcription Flanking Active TSS Strong transcription Enhancers Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:120 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:102301400-102322400	Weak transcription	Spleen	Spleen
2	chr11:102304000-102322400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr11:102304200-102322000	Weak transcription	Fetal Muscle Trunk	muscle
4	chr11:102309600-102322400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr11:102309800-102322400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr11:102310000-102321600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr11:102310200-102322400	Weak transcription	Lung	lung
8	chr11:102316800-102322000	Enhancers	Primary neutrophils fromperipheralblood	blood
9	chr11:102318000-102322000	Enhancers	Primary monocytes fromperipheralblood	blood
10	chr11:102318200-102321600	Weak transcription	Osteobl	bone
11	chr11:102319000-102322000	Enhancers	Stomach Mucosa	stomach
12	chr11:102319000-102322400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
13	chr11:102319200-102322400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr11:102319400-102321600	Enhancers	Rectal Mucosa Donor 31	rectum
15	chr11:102319400-102321800	Flanking Active TSS	Primary T cells from cord blood	blood
16	chr11:102319400-102321800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr11:102319400-102322000	Enhancers	Primary B cells from peripheral blood	blood
18	chr11:102319600-102321600	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
19	chr11:102319600-102321600	Enhancers	Fetal Intestine Large	intestine
20	chr11:102319600-102322200	Weak transcription	Placenta	Placenta
21	chr11:102319600-102322400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
22	chr11:102319800-102321600	Enhancers	Cortex derived primary cultured neurospheres	brain
23	chr11:102319800-102321600	Enhancers	Fetal Kidney	kidney
24	chr11:102319800-102321600	Enhancers	K562	blood
25	chr11:102319800-102322000	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
26	chr11:102319800-102322000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
27	chr11:102319800-102322400	Flanking Active TSS	Primary hematopoietic stem cells	blood
28	chr11:102320000-102321600	Enhancers	iPS-18 Cell Line	embryonic stem cell
29	chr11:102320000-102321600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
30	chr11:102320000-102322400	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
31	chr11:102320000-102322400	Weak transcription	Gastric	stomach
32	chr11:102320200-102321600	Enhancers	Primary B cells from cord blood	blood
33	chr11:102320200-102321800	Flanking Active TSS	HUVEC	blood vessel
34	chr11:102320400-102321800	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr11:102320400-102321800	Flanking Active TSS	A549	lung
36	chr11:102320400-102322000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
37	chr11:102320400-102322000	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
38	chr11:102320400-102322400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr11:102320400-102322400	Bivalent/Poised TSS	Fetal Brain Male	brain
40	chr11:102320400-102322400	Flanking Active TSS	Dnd41	blood
41	chr11:102320400-102322600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
42	chr11:102320600-102321600	Flanking Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr11:102320600-102321600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
44	chr11:102320600-102321600	Flanking Active TSS	Brain Anterior Caudate	brain
45	chr11:102320600-102321600	Flanking Active TSS	Brain Substantia Nigra	brain
46	chr11:102320600-102321600	Flanking Active TSS	HSMM	muscle
47	chr11:102320600-102321800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
48	chr11:102320600-102321800	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
49	chr11:102320600-102321800	Flanking Active TSS	Liver	Liver
50	chr11:102320600-102322000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links